Gensatz
Bei diesem Ansatz wird eine funktionsfähige Version des CASK-Gens in den Körper eingebracht, um das defekte Gen zu ersetzen. 👉 Man kann sich das so vorstellen, als würde man eine neue Gebrauchsanweisung hinzufügen, wenn die ursprüngliche beschädigt ist.
Wird es bei CASK-Erkrankungen wirken?
Gene replacement has been licenced for other neurological diseases like Spinal Muscular Atrophy (SMA) and AADC deficiency. For CASK disorders, getting the right "dose" will be of vital importance, delivery to the brain is difficult and immune response risks are high. A gene replacement trial for a similar disorder (STXBP1) has been halted following the death of a child in the trial. The CASK community were hopeful that the technology used in this gene therapy would be one it could harness for its own clinical trials. The cause of the death is still unknown.